Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. The company has three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload.
Quick Stats
Jan 30, 202656.4
AI Score
HOLD0.73
Volume Ratio
Mar 19, 2026
Next Earnings
15
+ve Days (30d)
14
-ve Days (30d)
MGNX Stock Summary
Last updated Jan 30, 2026
MGNX is currently trading at $1.83, positioned above its 200-day moving average of $1.59, indicating a long-term uptrend. The stock has a 52-week range of $0.98965 to $3.155.
Technical Analysis: The 50-day moving average stands at $1.6, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 57.613, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.061, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates MGNX at 56.4/100 with a HOLD recommendation.
MGNX (MacroGenics, Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 57.613 |
| CMF (20) | 0.061 |
| ROC (10) | 7.647 |
| ADX (14) | 26.465 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.067 |
| AROONOSC (14) | 35.714 |
| WILLAMS %R (14) | -39.437 |
| MFI (14) | 45.741 |
MGNX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
MGNX Price vs Max Options Open Interest
MGNX Max Change In Options Open Interest
MGNX Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MGNX Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MGNX Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MGNX Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MacroGenics, Inc. is above both 50 Day and 200 Day SMA which is considered Bullish.
MGNX Moving Averages Analysis
MacroGenics, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
MacroGenics, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
MGNX (MacroGenics, Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 1.8 |
| 20 | 1.77 |
| 30 | 1.71 |
| 50 | 1.6 |
| 100 | 1.63 |
| 200 | 1.59 |
MGNX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 115.8 million |
| Earnings/Share ($) | -1.15 |
| Net Proft Margin (%) | -0.5946 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.885 |
| EPS Estimate Next Year ($) | -1.7167 |
| WallStreet Target Price ($) | 3.4 |
| Most Recent Quarter |